ResearcherUniversity of Pavol Jozef ŠafárikActive in the last 2 years

Jana Sabová

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-2821-8150; OpenAlex author ID A5042140581. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2026: 1 paper

Papers 1

Tigecycline Enhances Sensitivity to FOLFIRINOX and Gemcitabine/Nab-Paclitaxel in Pancreatic Ductal Adenocarcinoma In Vitro Models Co-author DOI 10.1007/s44411-026-00676-1 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Matúš Čoma · 1 shared paper, 2026 · strength 0.39
- Paper Tigecycline Enhances Sensitivity to FOLFIRINOX and Gemcitabine/Nab-Paclitaxel in Pancreatic Ductal Adenocarcinoma In Vi… DOI 10.1007/s44411-026-00676-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.